Elisa Protocol Antibody Concentration
Human Glucose concentration-Glucose concentration- ELISA Kit |
|
QY-E05365 |
Qayee Biotechnology |
96T |
EUR 400 |
Antibody Elisa Laboratories manufactures the elisa protocol antibody concentration reagents distributed by Genprice. The Elisa Protocol Antibody Concentration reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact antibody elisa. Other Elisa products are available in stock. Specificity: Elisa Category: Protocol Group: Antibody Concentration
Schenk and Hildebrandt Vitamin Concentration (Syringe Vials) |
|
Bio-WORLD |
100 mL |
Ask for price |
Antibody Concentration information
UPCK™ Urine Protein Concentration Kit |
|
UPCK-25 |
Biotech Support Group |
25 preps |
EUR 1143.6 |
|
Description: Urine Protein Enrichment Kit |
Cas9 Nuclease Protein (High Concentration) |
|
K108 |
ABM |
40 µg (250pmol) Volume: 25µL |
EUR 80 |
|
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. |
PE Streptavidin (High Concentration) |
|
GT17634 |
Sony |
500 µg |
Ask for price |
|
|
APC Streptavidin (High Concentration) |
|
GT17633 |
Sony |
500 µg |
Ask for price |
|
|
saCas9 Nuclease Protein (High Concentration) |
|
K144 |
ABM |
32.5 µg (250pmol) Volume: 25µL |
EUR 155 |
|
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT). |
Minimal Inhibitory Concentration Kit |
|
K195-2500 |
Biovision |
each |
EUR 836.4 |
Minimal Inhibitory Concentration Kit |
|
K195-500 |
Biovision |
each |
EUR 574.8 |
AvaI -HC unit: 330, High Concentration |
|
YRAVA1-HC |
Yeastern Biotech |
1 vial |
Ask for price |
SacI -HC unit: 1500, High Concentration |
|
YRSAC1-HC |
Yeastern Biotech |
1 vial |
Ask for price |
BCA Protein concentration determination kit |
|
BC016-500ml |
ELK Biotech |
500ml |
EUR 110 |
Cas9 Null Mutant Protein (High Concentration) |
|
K140 |
ABM |
40 µg (250pmol) Volume: 25µL |
EUR 135 |
|
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 Null Mutant Protein is created by mutating both cleavage domains of the wild type Cas9 (D10A and H840A). Such a Cas9 protein retains its ability to bind to genomic DNA through gRNA:genomic DNA base pairing, however, unlike Cas9 Nuclease and Cas9 Nickase, where permanent gene disruption can be achieved, the Cas9 Null Mutant does not introduce any genome modifications. Therefore, this protein can provide a useful negative control for CRISPR experiments. In addition, binding of the Null Mutant can act as a roadblock to hinder transcription, thus offering a useful tool to achieve reversible knock-down of gene expression.;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. |